Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3)
2007
A new class of bicyclic pyrrolopyrimidine-based Janus kinase 3 (JAK-3) inhibitors are described. Many of these inhibitors showed low nanomolar activity against JAK-3.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
7
References
52
Citations
NaN
KQI